ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ)
CNY 9.27
(1.64%)
CNY 9.27
(1.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 799.3 Million | 828.99 Million | 930.37 Million | 848.07 Million | 1.13 Billion | 1.13 Billion |
| Cost of Revenue | 257.47 Million | 250.89 Million | 282.2 Million | 261.45 Million | 277.32 Million | 267.77 Million |
| Gross Profit | 541.83 Million | 578.1 Million | 648.17 Million | 586.61 Million | 854.47 Million | 868.72 Million |
| Operating Expenses | 501.67 Million | 590.06 Million | 653.3 Million | 752.05 Million | 861.04 Million | 817.83 Million |
| Selling, General and Administrative Expenses | 364.23 Million | 450.96 Million | 511.02 Million | 589.16 Million | 722.25 Million | 660.87 Million |
| Research and Development Expenses | 49.97 Million | 54.52 Million | 57.11 Million | 72.39 Million | 48.95 Million | 53.54 Million |
| Other Expenses | 15.12 Million | 25.07 Million | 14.09 Million | 16.72 Million | 43.01 Million | 29.57 Million |
| Cost and Expenses | 758.88 Million | 840.95 Million | 935.5 Million | 1.01 Billion | 1.13 Billion | 1.08 Billion |
| Operating Income | 40.15 Million | -115.09 Million | -79.57 Million | -315.11 Million | -41.11 Million | -14.8 Million |
| Interest Expense | 33.29 Million | 46.06 Million | 49.17 Million | 54.68 Million | 18.11 Million | 13.59 Million |
| Income Tax Expense | 6.55 Million | 7.97 Million | 9.06 Million | -17.81 Million | 3.67 Million | 5 Million |
| Earnings before Tax | 55.27 Million | -90.02 Million | -65.47 Million | -298.38 Million | 1.89 Million | 14.77 Million |
| Net Income | 25.19 Million | -118.57 Million | -91.43 Million | -262.36 Million | 5.29 Million | 7.24 Million |
| Earnings Per Share Basic | 0.10 | -0.50 | -0.40 | -1.23 | 0.03 | 0.03 |
| Earnings Per Share Diluted | 0.10 | -0.50 | -0.40 | -1.23 | 0.03 | 0.03 |
| Weighted Average Shares Outstanding | 241.61 Million | 237.06 Million | 227.97 Million | 213.22 Million | 208.3 Million | 208.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 241.61 Million | 237.06 Million | 227.97 Million | 213.22 Million | 208.3 Million | 208.07 Million |
| Gross Margin | 0.68 | 0.70 | 0.70 | 0.69 | 0.75 | 0.76 |
| EBIT Margin | 0.16 | 0.09 | 0.10 | -0.10 | 0.10 | 0.12 |
| Profit Margin | 0.03 | -0.14 | -0.10 | -0.31 | 0.00 | 0.01 |
| EBITDA | 127.06 Million | 25.13 Million | 40.52 Million | -177.15 Million | 57.72 Million | 88.93 Million |
| Earnings Before Tax Margin | 0.05 | -0.14 | -0.09 | -0.37 | -0.04 | -0.01 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 207.7 Million | 211.61 Million | 187.9 Million | 227.36 Million | 799.3 Million | 206.35 Million |
| Cost of Revenue | 67.29 Million | 69.17 Million | 64.5 Million | 72.09 Million | 257.47 Million | 62.04 Million |
| Gross Profit | 140.4 Million | 142.44 Million | 123.4 Million | 155.27 Million | 541.83 Million | 144.31 Million |
| Operating Expenses | 118.05 Million | 118.73 Million | 104.53 Million | 137.33 Million | 505.5 Million | 124.79 Million |
| Selling, General and Administrative Expenses | 171.78 Million | 68.82 Million | 93.7 Million | 38.75 Million | - | 145.56 Million |
| Research and Development Expenses | 7.76 Million | 16.5 Million | 12.04 Million | 10.89 Million | - | 15.84 Million |
| Other Expenses | -61.48 Million | 1.67 Million | 1.21 Million | 4.11 Million | 15.12 Million | 2.16 Million |
| Cost and Expenses | 185.35 Million | 187.91 Million | 169.03 Million | 209.42 Million | 762.97 Million | 186.84 Million |
| Operating Income | 20.35 Million | 22.91 Million | 18.86 Million | 47.07 Million | 40.15 Million | 15.91 Million |
| Interest Expense | 4.17 Million | 4.05 Million | 4.11 Million | 6.25 Million | 33.15 Million | 2.61 Million |
| Income Tax Expense | 4.7 Million | 445.88 Thousand | 1.1 Million | 2.77 Million | 6.55 Million | 25.18 Thousand |
| Earnings before Tax | 22.77 Million | 24.58 Million | 26.04 Million | 51.19 Million | 55.27 Million | 18.07 Million |
| Net Income | 10.65 Million | 15.21 Million | 18.28 Million | 38.88 Million | 25.19 Million | 10.43 Million |
| Earnings Per Share Basic | 0.04 | 0.06 | 0.08 | 0.16 | - | 0.04 |
| Earnings Per Share Diluted | 0.04 | 0.06 | 0.08 | 0.16 | - | 0.04 |
| Weighted Average Shares Outstanding | 248.66 Million | 241.61 Million | 241.61 Million | 241.61 Million | 241.61 Million | 241.61 Million |
| Weighted Average Shares Outstanding (Diluted) | 248.66 Million | 241.61 Million | 241.61 Million | 241.61 Million | 241.61 Million | 241.61 Million |
| Gross Margin | 0.68 | 0.67 | 0.66 | 0.68 | 0.68 | 0.70 |
| EBIT Margin | 0.13 | 0.12 | 0.15 | 0.20 | - | 0.10 |
| Profit Margin | 0.05 | 0.07 | 0.10 | 0.17 | 0.03 | 0.05 |
| EBITDA | 26.94 Million | 25.52 Million | 28.41 Million | 45.13 Million | - | 21.59 Million |
| Earnings Before Tax Margin | 0.10 | 0.11 | 0.10 | 0.21 | 0.05 | 0.08 |
1460
LEO
1062
LLY
4391
IE